Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Viracor-IBT Laboratories Inc. Stories

2013-12-10 16:24:19

Combined diagnostic expertise will help more U.S. transplant patients LEE'S SUMMIT, Mo., Dec. 10, 2013 /PRNewswire/ -- Viracor-IBT Laboratories, Inc. announced today it has closed on its previously announced transaction to purchase assets associated with the laboratory operations of the National Institute of Transplantation (NIT), a non-profit organization committed to advancing the science and practice of transplantation. NIT made the decision to transfer its laboratory operations...

2013-11-13 12:27:28

Expands laboratory operations to help more U.S. transplant patients LEE'S SUMMIT, Mo., Nov. 13, 2013 /PRNewswire/ -- Viracor-IBT Laboratories, Inc. announced today it has signed a definitive agreement to purchase all assets associated with the laboratory operations of the National Institute of Transplantation (NIT), a non-profit organization committed to advancing the science and practice of transplantation. This includes the acquisition of NIT's Los Angeles, California-based...

2013-02-05 16:23:28

LEE'S SUMMIT, Mo., Feb. 5, 2013 /PRNewswire/ -- Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex(TM), Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. This includes the acquisition of Cylex's core product, ImmuKnow®, a noninvasive biomarker of immune function...